Strata Critical Medical
SRTA
127 hedge funds and large institutions have $181M invested in Strata Critical Medical in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 20 closing their positions.
90% more capital inflows, than outflows
Capital inflows: $16.6M | Capital outflows: $8.76M
59% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 29
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
8% more funds holding
Funds holding: 118 → 127 (+9)
2.1% more ownership
Funds ownership: 53.33% → 55.43% (+2.1%)
66% less call options, than puts
Call options by funds: $1.51M | Put options by funds: $4.48M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prelude Capital Management
New York
|
+$2.9M |
| 2 |
Cannell Capital
Alta,
Wyoming
|
+$2.81M |
| 3 |
ARK Investment Management
St. Petersburg,
Florida
|
+$1.49M |
| 4 |
HCA
Hurricane Capital Advisors
New York
|
+$1.44M |
| 5 |
BlackRock
New York
|
+$825K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.3M |
| 2 |
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$1.19M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$977K |
| 4 |
Deane Retirement Strategies
New Orleans,
Louisiana
|
-$700K |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$676K |
SRTA Hedge Fund Activity: Q2 2025 in Review
127 of the 7,632 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical (SRTA) for Q2 2025, worth a combined $181M — up 55% from $117M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new SRTA positions and 20 closed out — a net gain of 10 holders — while 46 added to existing stakes and 29 trimmed.
The largest buyer was Prelude Capital Management, opening a new position worth an estimated $2.9M. The largest seller was JP Morgan Chase, cutting an estimated $1.3M.
- 127 institutional investors held Strata Critical Medical (SRTA) as of Q2 2025, up from 118 in Q1 2025.
- Funds reported $181M of Strata Critical Medical stock for Q2 2025, up 55% quarter-over-quarter.
- 30 funds opened new Strata Critical Medical positions in Q2 2025 and 20 closed out, a net change of +10 holders.
- The largest Strata Critical Medical buyer in Q2 2025 was Prelude Capital Management, an estimated $2.9M added.
- The largest Strata Critical Medical seller in Q2 2025 was JP Morgan Chase, an estimated $1.3M sold.
Based on aggregated 13F filings for Q2 2025.